QT Imaging (NASDAQ:QTI) Research Coverage Started at Craig Hallum

Posted by George Bondi on Oct 8th, 2026

Craig Hallum started coverage on shares of QT Imaging (NASDAQ:QTI – Free Report) in a research report released on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $8.00 target price on the stock.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research note on Friday, July 10th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, QT Imaging currently has a consensus rating of “Hold” and a consensus target price of $8.00.

Read Our Latest Analysis on QT Imaging

QT Imaging Stock Down 0.4%

QTI stock opened at $2.57 on Monday. The firm has a market cap of $35.39 million, a price-to-earnings ratio of -1.64 and a beta of 0.02. QT Imaging has a 1-year low of $2.00 and a 1-year high of $8.50. The firm has a fifty day moving average price of $2.74 and a two-hundred day moving average price of $4.27. The company has a debt-to-equity ratio of 6.81, a current ratio of 3.10 and a quick ratio of 2.06.

QT Imaging (NASDAQ:QTI – Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). The business had revenue of $7.44 million during the quarter, compared to the consensus estimate of $7.60 million. QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%. Research analysts predict that QT Imaging will post -1.11 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in shares of QT Imaging by 116.5% during the second quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock valued at $250,000 after purchasing an additional 33,009 shares during the period. Polar Asset Management Partners Inc. acquired a new stake in QT Imaging in the second quarter worth about $210,000. Finally, Stonepine Capital Management LLC bought a new position in QT Imaging in the 2nd quarter valued at about $407,000. Institutional investors and hedge funds own 24.19% of the company’s stock.

QT Imaging Company Profile

(Get Free Report)

QT Imaging Holdings, Inc develops medical imaging technology designed to support breast cancer screening and diagnostic procedures. The company’s flagship product, QTscan, is a three-dimensional, transmission-based breast imaging system that uses ultrasound technology to produce images without ionizing radiation, breast compression or injectable contrast agents.

QTscan is intended for use by healthcare providers as an imaging tool for evaluating breast tissue, including in patients with dense breasts.